Prostate cancer decisions — 2024

The Board has remanded the claims for service connection for lymphoma and prostate cancer due to a pre-decisional duty to assist error, specifically regarding exposure to ionizing radiation during service.

The Board has remanded the claims of service connection for prostate cancer and Parkinson's disease due to additional evidence being added to the record.

The Veteran's claims for service connection for diabetes mellitus and prostate cancer are denied. The claim for diabetes mellitus is denied as there is no evidence of in-service exposure to an herbicide agent or treatment for meningitis that could have caused the current condition. The claim for prostate cancer is remanded due to insufficient information provided by the Veteran regarding his service.

The Board denied the Veteran's claims for service connection for prostate cancer and erectile dysfunction as due to prostate cancer or diabetes mellitus type II, finding no current diagnosis of prostate cancer and that secondary service connection cannot be established.

The Veteran's separate service connection for bladder cancer was denied as it constituted impermissible pyramiding, and the combined evaluation of both conditions should not exceed the existing rating for prostate cancer.

The appeal of the claim for service connection for right ear hearing loss is dismissed. The case is also remanded for additional development regarding a TDIU.

The Board dismissed the readjudication of service connection for healed fracture of the fibula, right leg, as it was already granted in a previous decision. Service connection for prostate cancer is not warranted due to lack of new and relevant evidence.

The Board has denied the Veteran's request to restore a 100% rating for prostate cancer, granted entitlement to TDIU based on prostate cancer residuals alone since July 1, 2024, and granted SMC at the housebound rate due to his service-connected disabilities.

The Veteran's claim of service connection for prostate cancer is remanded due to the inadequacy of a previous VA examination and the need for a new one.

The Veteran's prostate cancer is related to ionizing radiation during his active service.,His erectile dysfunction (ED) is proximately due to his prostate cancer, and he qualifies for special monthly compensation based on loss of use of a creative organ.,His bladder cancer is also proximately due to his prostate cancer.

The Veteran's claim for service connection for prostate cancer residuals and the award of special monthly compensation for loss of use of a creative organ are granted with an effective date of November 30, 2016.

The Board has remanded the Veteran's claims for service connection due to incomplete records and a need for additional medical opinions.

The Veteran's claim for an increased initial disability rating for CAD status post stents is denied. The effective date of service connection for prostate cancer and left foot pes planus, hallux valgus and degenerative joint disease first metatarsal phalangeal joint has been granted as April 8, 2010. The Veteran's claim for an earlier effective date for SMC based on loss of use of a creative organ is denied.

The Board has granted service connection for prostate cancer and neuroendocrine cancer, finding that the Veteran's cancers are at least as likely as not related to asbestos exposure during his military service.

The Veteran's prostate cancer residuals disability is rated at 60 percent, but not higher, due to urinary incontinence requiring the use of absorbent material changed more than four times per day. The rating does not include renal dysfunction.

The Veteran's claim for service connection is remanded due to the need for additional examinations and opinions regarding his prostate cancer, erectile dysfunction, urinary incontinence, and hypertension. The Board also found that new evidence submitted by the Veteran supports re-adjudicating his claim for service connection of prostate cancer.

The Board dismissed the appeal regarding a proposed reduction in disability rating for prostate cancer from 100 percent to zero (0) percent and proposed discontinuance of entitlement to special monthly compensation based on housebound because the proposed reductions were not final prior to being certified to the Board.

The Board has granted the appellant's claim for a total disability rating based on individual unemployability (TDIU) due to his service-connected disabilities, which prevent him from obtaining or maintaining substantially gainful employment.

The Veteran's initial claim for an increased rating for his service-connected bladder cancer and dysfunction is being remanded due to a failure to provide a VA examination to evaluate the extent of his prostate cancer residuals.

The Veteran's prostate cancer is presumed related to his exposure to herbicide agents while serving at Korat RTAFB in Thailand.,The Veteran's cause of death, metastatic prostate cancer, was also found to be due to his service-connected exposure to herbicides.